Literature DB >> 27016804

ACR Appropriateness Criteria Renal Cell Carcinoma Staging.

Raghunandan Vikram1, Michael D Beland2, M Donald Blaufox3, Courtney Coursey Moreno4, John L Gore5, Howard J Harvin6, Marta E Heilbrun7, Stanley L Liauw8, Paul L Nguyen9, Paul Nikolaidis10, Glenn M Preminger11, Andrei S Purysko12, Steven S Raman13, Myles T Taffel14, Zhen J Wang15, Robert M Weinfeld16, Erick M Remer12, Mark E Lockhart17.   

Abstract

Renal cell carcinoma accounts for 2%-3% of all visceral malignancies. Preoperative imaging can provide important staging and anatomic information to guide treatment decisions. Size of the primary tumor and degree of local invasion, such as involvement of perinephric fat or renal sinus fat, and tumor thrombus in renal veins and inferior vena cava are important detriments to local staging of primary tumor. Both kidneys are assessed for presence of other synchronous lesions. The ACR Appropriateness Criteria(®) are evidence-based guidelines for specific clinical conditions that are reviewed every three years by a multidisciplinary expert panel. The guideline development and review include an extensive analysis of current medical literature from peer-reviewed journals and application by the panel of a well-established consensus methodology (modified Delphi) to rate the appropriateness of imaging and treatment procedures. In those instances in which evidence is lacking or not definitive, expert opinion may be used to recommend imaging or treatment.
Copyright © 2016 American College of Radiology. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Appropriateness Criteria; CT; Imaging; MRI; Staging; renal cell carcinoma

Mesh:

Substances:

Year:  2016        PMID: 27016804     DOI: 10.1016/j.jacr.2016.01.021

Source DB:  PubMed          Journal:  J Am Coll Radiol        ISSN: 1546-1440            Impact factor:   5.532


  10 in total

Review 1.  Advances in medical imaging for the diagnosis and management of common genitourinary cancers.

Authors:  Mohammad H Bagheri; Mark A Ahlman; Liza Lindenberg; Baris Turkbey; Jeffrey Lin; Ali Cahid Civelek; Ashkan A Malayeri; Piyush K Agarwal; Peter L Choyke; Les R Folio; Andrea B Apolo
Journal:  Urol Oncol       Date:  2017-05-12       Impact factor: 3.498

2.  Society of Abdominal Radiology disease-focused panel on renal cell carcinoma: update on past, current, and future goals.

Authors:  Matthew S Davenport; Hersh Chandarana; Nicole E Curci; Ankur Doshi; Samuel D Kaffenberger; Ivan Pedrosa; Erick M Remer; Nicola Schieda; Atul B Shinagare; Andrew D Smith; Zhen J Wang; Shane A Wells; Stuart G Silverman
Journal:  Abdom Radiol (NY)       Date:  2018-09

Review 3.  An overview of non-invasive imaging modalities for diagnosis of solid and cystic renal lesions.

Authors:  Ravinder Kaur; Mamta Juneja; A K Mandal
Journal:  Med Biol Eng Comput       Date:  2019-11-21       Impact factor: 2.602

Review 4.  Imaging for Metastatic Renal Cell Carcinoma.

Authors:  Soumya V L Vig; Elcin Zan; Stella K Kang
Journal:  Urol Clin North Am       Date:  2020-06-11       Impact factor: 2.241

Review 5.  Imaging of Solid Renal Masses.

Authors:  Fernando U Kay; Ivan Pedrosa
Journal:  Urol Clin North Am       Date:  2018-06-15       Impact factor: 2.241

6.  Renal pelvic and ureteral wall thickening in renal cell carcinoma: prevalence, cause, and clinical significance.

Authors:  Kotaro Yoshida; Mami Hamaoka; Satoshi Kobayashi; Junichi Matsumoto; Dai Inoue; Norihide Yoneda; Toshifumi Gabata
Journal:  Jpn J Radiol       Date:  2019-10-24       Impact factor: 2.374

7.  Von Hippel-Lindau syndrome and renal tumours: radiological diagnostic and treatment options. A case report and literature review.

Authors:  Audrius Untanas; Mantas Trakymas; Indrė Lekienė; Rūta Briedienė
Journal:  Acta Med Litu       Date:  2020

8.  Renal Cell Carcinoma with Unusual Visceral and Cutaneous Metastasis.

Authors:  Vivek Kumar Saini; Alen Elias Mammoottil; Aftab Hasan Nazar; Manish Ora; Sanjay Gambhir
Journal:  Indian J Nucl Med       Date:  2021-12-15

Review 9.  Secondary Tumors of the Urinary System: An Imaging Conundrum.

Authors:  Ali Devrim Karaosmanoglu; Mehmet Ruhi Onur; Musturay Karcaaltincaba; Deniz Akata; Mustafa Nasuh Ozmen
Journal:  Korean J Radiol       Date:  2018-06-14       Impact factor: 3.500

10.  Metabolic tumour volume on 18F-FDG PET/CT predicts extended pathological T stages in patients with renal cell carcinoma at staging.

Authors:  Dongwoo Kim; Narae Lee; Woong Kyu Han; Mijin Yun; Suk Hyun Lee; Hyun Jeong Kim; Hye-Suk Hong; Jee Soo Park; Nam-Hoon Cho; Young Deuk Choi; Won Sik Ham; Seung Hwan Lee
Journal:  Sci Rep       Date:  2021-12-06       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.